Health and Human Services Secretary Robert F. Kennedy Jr. is cancelling 22 mRNA vaccine contracts funded by BARDA. Without evidence, Kennedy claimed these vaccines fail to protect effectively against ...

A next-generation Vertex Pharmaceuticals pain drug failed to beat a placebo in a Phase 2 clinical trial. Despite the disappointing outcome in bunionectomy pain, the company is continuing ...

Healthcare AI progress could soon stall due to fragmented, inaccessible data systems, warned OMNY Health CEO Mitesh Rao. He said that scalable AI requires a more interoperable data infrastructure ...

With HealthTap's new direct virtual primary care program, members get ongoing access to a primary care doctor of their choosing through video visits and messaging.

Sarepta Therapeutics is still assessing how best to prevent liver injury from its commercialized Duchenne muscular dystrophy gene therapy. But Sarepta partner Hansa Biopharma has encouraging ...

In a new analysis, the American Medical Association detailed the lack of competition among pharmacy benefit managers and ...

In a new action plan, the White House aims to boost the country’s AI innovation through deregulation, infrastructure ...

The Train More Nurses Act would help address these challenges by directing the U.S. Department of Health and Human Services (HHS), as well as the U.S. Labor Department, to conduct a review of ...

Sutter Health is scaling its use of Flosonics Medical’s wearable ultrasound device, which helps clinicians quickly and noninvasively assess fluid responsiveness. The tool’s ease of use has ...

In this episode, we’re joined by Dr. Keith Berkle, chair of Privia Women’s Health, who discusses the challenges OBGYNs face in transitioning to value-based care.

Even if you don't have all the answers, communication plays a critical role in reducing stress levels and fostering feelings of stability, confidence, and psychological well-being.

The healthcare landscape is thriving with innovation, from AI advancements to digital platforms and substantial venture capital to the tune of $49 billion since 2021. Yet patients aren’t exactly ...